Skip to main content
SpringerLink
Log in

Rare Diseases Epidemiology

  • Book
  • © 2010

Overview

Editors:
  1. Manuel Posada de la Paz

    1. , Instituto de Investigaciñon en Enfermeda, Instituto de Salud Carlos III, Madrid, Spain

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Stephen C. Groft

    1. , Office of Rare Diseases Research, National Institutes of Health, Bethesda, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • It is the first book edited on Rare Diseases Epidemiology Develops a comprehensive approach to the rare diseases epidemiological problems Teach the best knowledge currently available Opens future perspectives for health planning and decision making Provides a general framework for physicians, public health experts and
  • basic researchers

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 686)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (28 chapters)

  1. Front Matter

    Pages i-xxii
    Download chapter PDF

  2. Rare Diseases

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Rare Diseases – Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data

      • Stephen C. Groft, Manuel Posada de la Paz
      Pages 3-14

  3. Methods and Approaches

    1. Front Matter

      Pages 15-15
      Download chapter PDF

    2. Rare Diseases Epidemiology Research

      • Manuel Posada de la Paz, Ana Villaverde-Hueso, Verónica Alonso, Sándor János, Óscar Zurriaga, Marina Pollán et al.
      Pages 17-39

    3. Evidence-Based Medicine and Rare Diseases

      • Simon Day
      Pages 41-53

    4. Prevention, Diagnosis and Services

      • Eva Bermejo, María Luisa Martínez-Frías
      Pages 55-75

    5. The Importance of Case Reports in Advancing Scientific Knowledge of Rare Diseases

      • John C. Carey
      Pages 77-86

    6. Patient Registries: Utility, Validity and Inference

      • Rachel Richesson, Kendra Vehik
      Pages 87-104

    7. Biobanking in Rare Disorders

      • Hanns Lochmüller, Peter Schneiderat
      Pages 105-113

    8. Evaluation of the Validity and Utility of Genetic Testing for Rare Diseases

      • Scott D. Grosse, Lisa Kalman, Muin J. Khoury
      Pages 115-131

    9. Population-Based Surveillance for Rare Congenital and Inherited Disorders: Models and Challenges

      • Jodi M. Jackson, Krista S. Crider, Richard S. Olney
      Pages 133-150

    10. Statistical Methods for the Geographical Analysis of Rare Diseases

      • Virgilio Gómez-Rubio, Antonio López-Quílez
      Pages 151-171

    11. Clinical Trials and Rare Diseases

      • Joachim Werner Otto Gerß, Wolfgang Köpcke
      Pages 173-190

  4. Pharmacoepidemiology

    1. Front Matter

      Pages 191-191
      Download chapter PDF

    2. A Regulatory Overview About Rare Diseases

      • Jordi Llinares
      Pages 193-207

  5. Economics and Social Epidemiology

    1. Front Matter

      Pages 209-209
      Download chapter PDF

    2. Economic Considerations in the Provision of Treatments for Rare Diseases

      • Christopher McCabe, Richard Edlin, Jeff Round
      Pages 211-222

    3. Rare Diseases Social Epidemiology: Analysis of Inequalities

      • Anna Kole, François Faurisson
      Pages 223-250

    4. Quality of Life and Rare Diseases

      • Luis Rajmil, Lilisbeth Perestelo-Pérez, Michael Herdman
      Pages 251-272
Back to top

Keywords

About this book

In our etiologic research, we epidemiologists need to leave behind the concepts of ‘cohort’ study and ‘case–control’ study and adopt that of the etiologic study as the singular substitute for these. With this sentence, the famous epidemiologist Professor Olli S. Miettinen began his personal re ection on the future of the epidemiology [1]. He sought to highlight the fact that the role of the epidemiologist should be mainly focused on aetiological research. Nevertheless, the widespread idea still exists that epidemiology is limited to purely providing gures and descriptive data on the frequency and distribution of disease. Indeed, it is more than likely that the precise aim of those rst classic epidemiological steps, i. e. , methods essentially based on describing the distri- tion of a given disease, is still not all that well understood by many scientists, let alone the general public. Such descriptions seek to generate hypotheses and afford explanations for key factors (be these risk factors or the presumable causes th- selves), which might justify differences in terms of persons, time or place and, in turn, ultimately serve to develop preventive measures and/or gain quality-adjusted life years. To restrict the goals of epidemiology to activities exclusively concerned with reporting gures or even complex statistical results is a great mistake, one that renders it dif cult to take full advantage of the epidemiologist’s true role, which is “to study disease determinants and to assess the actual impact of factors involved in their development, distribution and dissemination”.

Reviews

From the reviews:

“It covers the common components of epidemiology and its collaborating disciplines to demonstrate the concepts, methods, and examples of the epidemiology of rare diseases. … it is a useful resource for epidemiologists, the book can be used by other researchers and by funding agencies, foundations, and policy makers. … This is an important state-of-the-art book in rare disease epidemiology. … an extremely important contribution to the field and will be a useful reference in several disciplines.” (James C. Torner, Doody’s Review Service, July, 2011)

“The book is very well written, and deals with its subject delineated above comprehensively. … the amount of information presented is very impressive. The multitude of the data presented in the reviewed work make it indispensable for anyone potentially active in the field of the rare diseases … . this volume will remain the major reference book for quite some time, and highly recommend it to the healthcare planners, general practitioners and those specializing in the field of the rare diseases … .” (K. Pagava and I. Paghava, Georgian Medical News, Vol. 193 (4), 2011)

Editors and Affiliations

  • , Instituto de Investigaciñon en Enfermeda, Instituto de Salud Carlos III, Madrid, Spain

    Manuel Posada de la Paz

  • , Office of Rare Diseases Research, National Institutes of Health, Bethesda, USA

    Stephen C. Groft

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation